Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy

International Journal of Hyperthermia

Volumn 23, Issue 5, 2007, Pages 431-442

  Sugarbaker, P H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

Appendiceal cancer; Colorectal cancer; Gastric cancer; Ovarian cancer; Peritoneal mesothelioma

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; MELPHALAN; MITOMYCIN C; MITOXANTRONE; OXALIPLATIN; SODIUM THIOSULFATE;

ANTINEOPLASTIC ACTIVITY; APPENDIX CANCER; AREA UNDER THE CURVE; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CANCER PREVENTION; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; COLON RESECTION; CYTOREDUCTIVE SURGERY; CYTOTOXICITY; DIGESTIVE SYSTEM CANCER; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG PENETRATION; DRUG TUMOR LEVEL; DRUG UPTAKE; GASTRECTOMY; GYNECOLOGIC CANCER; HUMAN; HYPERTHERMIC THERAPY; LOW DRUG DOSE; NEPHROTOXICITY; NONHUMAN; OVARY CANCER; PERITONEUM CANCER; PERITONEUM MESOTHELIOMA; PHARMACODYNAMICS; PLEURA MESOTHELIOMA; PLEURECTOMY; POSTOPERATIVE CARE; REVIEW; SINGLE DRUG DOSE; STOMACH CANCER; SYSTEMIC DISEASE; SYSTEMIC THERAPY;

ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; GASTROINTESTINAL NEOPLASMS; GENITAL NEOPLASMS, FEMALE; HUMANS; HYPERTHERMIA, INDUCED; PERITONEAL NEOPLASMS;

EID: 34547994951     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730701455318     Document Type: Review

References (53)

1. Chu, DZ, Lang, NP, Thompson, C., Osteen, PK and Westbrook, KC (1989) Peritoneal carcinomatosis in nongynecologic malignancy: A prospective study of prognostic factors. Cancer, 63, pp. 364-367.
2. Sadeghi, B., Arvieux, C., Glehen, O., Beaujard, AC, Rivoire, M., Baulieux, J., Fontaumard, E., Brachet, A., Caillot, JL and Faure, JL (2000) Peritoneal carcinomatosis from non-gynecologic malignancies. Result of the EVOCAPE 1 multicentric prospective study. Cancer, 88, pp. 358-363.
3. Jayne, DG, Fook, S. and Seow-Choen, F. (2002) Peritoneal carcinomatosis from colorectal cancer. Br J Surg, 89, pp. 1545-1550.
4. Whang, I., Chung, HY, Averbach, A. and Sugarbaker, PH (2001) Indications for early postoperative intraperitoneal chemotherapy for advanced gastric cancer: Results of a prospective randomized trial. World J Surg, 25, pp. 985-990.
5. Glehen, O., Gilly, F. and Sugarbaker, PH (2003) New perspectives in the management of colorectal cancer: What about peritoneal carcinomatosis?. Scand J Surg, 92, pp. 178-179.
6. Verwaal, VJ, Van Ruth, S., de Bree, E., Van Sloothen, GW, Van Tinteren, H., Boot, H. and Zoetmulder, FAN (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol, 21, pp. 3737-3743.
7. Link, KH, Roitman, M., Holtappels, M., Runnebaum, I., Urbanzyk, H., Leder, G. and Staib, L. (2003) Intraperitoneal chemotherapy with mitoxantrone in malignant ascites. Surg Oncol Clin N Am, 12, pp. 865-872.
8. Sugarbaker, PH (1996) Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. Peritoneal Carcinomatosis: Principles of Management, pp. 79-100. Kluwer, Boston
9. Carmignani, CP, Sugarbaker, TA, Bromley, CM and Sugarbaker, PH (2003) Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread. Cancer Metastasis Rev, 22, pp. 465-472.
10. Sugarbaker, PH (1995) Peritonectomy procedures. Ann Surg, 221, pp. 29-42.
11. Weiss, L. (1986) Metastatic inefficiency: Causes and consequences. Cancer Rev, 3, pp. 1-24.
12. Schott, A., Vogel, I., Krueger, U., Kalthoff, H., Schreiber, HW, Schmiegel, W., Henne-Bruns, D., Kremer, B. and Juhl, H. (1998) Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg, 227, pp. 372-379.
13. Flessner, MF, Dedrick, RL and Schultz, JS (1985) A distributed model of peritoneal-plasma transport: Analysis of experimental data in the rat. Am J Physiol, 248, pp. 413-424.
14. Alberts, DS, Liu, PY, Hannigan, EV, O'Toole, R., Williams, SD, Young, JA, Franklin, EW, Clarke-Pearson, DL, Malviya, VK and DuBeshter, B. (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Eng J Med, 335, pp. 1950-1955.
15. Markman, M., Bundy, BN and Alberts, DS (2001) Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol, 19, pp. 1001-1007.
16. Armstrong, DK, Bundy, B., Wenzel, L., Huang, HQ, Baergen, R., Lele, S., Copeland, LJ, Walker, JL and Burger, RA (2006) Gynecologic Oncology Group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med, 354, pp. 34-43.
17. Engelhardt, R. (1987) Hyperthermia and drugs. Recent Results Cancer Res, 104, pp. 136-203.
18. Dahl, O. (1988) Interaction of hyperthermia and chemotherapy. Recent Results Cancer Res, 107, pp. 157-169.
19. Meyer, JL (1989) Kapp DS, Fessenden P, Hahn GH. Hyperthermic oncology: Current biology, physics and clinical results. Pharmac Ther, 42, pp. 251-288.
20. Urano, M., Kuroda, M. and Nishimura, Y. (1999) Invited review for the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia, 15, pp. 79-107.
21. Marmor, JB, Kozak, D. and Hahn, GM (1979) Effects of systemically administered bleomycin or adriamycin with local hyperthermia on primary tumor and lung metastases. Cancer Treat Rep, 63, pp. 1279-1290.
22. Mella, O. and Dahl, O. (1985) Timing of combined hyperthermia and 1,3-bis(2-chloroethyl)-1-nitrosurea or cis-diamminedichloroplatinum in BD IX rats with BT4A tumours. Anticancer Res, 5, pp. 259-264.
23. Dahl, O. and Mella, O. (1983) Effect of timing and sequence of hyperthermia and cyclophosphamide on a neurogenic rat tumor (BT4A) in vivo. Cancer, 52, pp. 983-987.
24. Mohamed, F., Stuart, OA, Glehen, O., Urano, M. and Sugarbaker, PH (2004) Docetaxel and hyperthermia: Factors that modify thermal enhancement. J Surg Oncol, 88, pp. 14-20.
25. Mohamed, F., Stuart, OA, Glehen, O., Urano, M. and Sugarbaker, PH (2006) Optimizing factors which modify thermal enhancement of melphalan in a spontaneous murine tumor. Cancer Chemother Pharmacol, 58, pp. 719-724.
26. Los, G., Smals, OAG, Van Vugt, MJH, Van der Vlist, M., Engelse, L den, McVie, JG and Pinedo, HM (1992) A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity. Cancer Res, 52, pp. 1252-1258.
27. Jacquet, P., Averbach, A., Stuart, OA, Chang, D. and Sugarbaker, PH (1998) Hyperthermic intraperitoneal doxorubicin: Pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother Pharmacol, 41, pp. 147-154.
28. Hahn, GM and Li, GC (1982) Interactions of hyperthermia and drugs: Treatments and probes. Nat Cancer Inst Monogr, 61, pp. 317-323.
29. Ozols, RF, Locker, GY, Doroshow, JH, Grotzinger, KR, Myers, CE and Young, RC (1979) Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer. Cancer Res, 39, pp. 3209-3214.
30. Flessner, MF, Dedrick, RL and Schultz, JS (1985) A distributed model of peritoneal-plasma transport: Analysis of experimental data in the rat. Am J Physiol, 248, pp. 413-424.
31. Sugarbaker, PH, Mora, JT, Carmignani, P., Stuart, OA and Yoo, D. (2005) Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist, 10, pp. 112-122.
32. Sugarbaker, PH (2005) An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution. J Surg Oncol, 92, pp. 142-146.
33. Jacquet, P., Averbach, A., Stephens, AD, Stuart, OA, Chang, D. and Sugarbaker, PH (1998) Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: Pharmacokinetic studies. Oncology, 55, pp. 130-138.
34. Verwaal, VJ, Van Tinteren, H., Van Ruth, S. and Zoetmulder, FAN (2004) Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg, 91, pp. 739-746.
35. Elias, D., Pocard, M., Sideris, L., Ede, C., Ducreux, M., Boige, V. and Lasser, P. (2004) Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin. Br J Surg, 91, pp. 455-456.
36. Zylberberg, B., Dormont, D., Madelenat, P. and Darai, E. (2004) First-line intraperitoneal cisplatin-paclitaxel and intravenous ifosfamide in stage IIIc ovarian epithelial cancer. Eur J Gynaecol Oncol, 25, pp. 327-332.
37. Sugarbaker, PH and Chang, D. (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol, 6, pp. 727-731.
38. Sugarbaker, PH (2006) New standard of care for appendiceal epithelial malignancies and pseudomyxoma peritonei syndrome. Lancet Oncol, 7, pp. 69-76.
39. Gough, DB, Donohue, JH, Schutt, AJ, Gonchoroff, N., Goellner, JR, Wilson, TO, Naessens, JM, O'Brien, PC and Van Heerden, JA (1994) Pseudomyxoma peritonei: Long-term patient survival with an aggressive regional approach. Ann Surg, 2, pp. 112-119.
40. Misdraji, J., Yantiss, RK, Graeme-Cook, FM, Balis, UJ and Young, RH (2003) Appendiceal mucinous neoplasms: A clinicopathologic analysis of 107 cases. Am J Surg Pathol, 27, pp. 1089-1103.
41. Miner, TJ, Shia, J., Jaques, DP, Klimstra, DS, Brennan, MF and Coit, DG (2005) Long-term survival following treatment of pseudomyxoma peritonei: An analysis of surgical therapy. Ann Surg, 241, pp. 300-308.
42. Yan, TD, Zappa, L., Edwards, G., Alderman, R., Marquardt, CE and Sugarbaker, PH (2007) Perioperative outcomes of cytoreductive surgery perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database. J Surg Oncol
43. Feldman, AL, Libutti, SK, Pingpank, JF, Bartlett, DL, Beresnev, TH, Mavroukakis, SM, Steinberg, SM, Liewehr, DJ, Kleiner, DE and Alexander, HR (2003) Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol, 21, pp. 4560-4567.
44. Sugarbaker, PH, Yan, TD, Stuart, OA and Yoo, D. (2006) Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol, 32, pp. 644-647.
45. Taub, RN, Hesdorffer, ME and Keohan, ML (2005) Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for malignant peritoneal mesothelioma (MPM). J Clin Oncol
46. Deraco, M., Nonaka, D., Baratti, D., Casali, P., Rosai, J., Younan, R., Salvatore, A., Cabras, AD and Kusamura, S. (2006) Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol, 13, pp. 229-237.
47. Richards, WG, Zellos, L., Bueno, R., Jaklitsch, MT, Janne, PA, Chirieac, LR, Dekkers, RJ, Hartigan, PM and Capalbo, L. (2006) Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol, 10, pp. 1561-1567.
48. Glehen, O., Kwiatkowski, F., Sugarbaker, PH, Elias, D., Levine, EA, De Simone, M., Barone, R., Yonemura, Y., Cavaliere, F. and Quenet, F. (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol, 22, pp. 3284-3292.
49. Yan, TD, Black, D., Savady, R. and Sugarbaker, PH (2006) Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol, 24, pp. 4011-4019.
50. Sugarbaker, PH (1999) Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol, 43, pp. S15-S25.
51. Xu, DZ, Zhan, YQ, Sun, XW, Cao, SM and Geng, QR (2004) Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol, 10, pp. 2727-2730.
52. Bijelic, L., Jonson, A. and Sugarbaker, PH (2007) Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol
53. Sugarbaker, PH, Alderman, R., Edwards, G., Marquardt, CE, Gushchin, V., Esquivel, J. and Chang, D. (2006) Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol, 13, pp. 635-644.